NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine

Victor A.D. Holanda(Universidade Federal do Rio Grande do Norte), Elaine C. Gavioli(University of Ferrara), Wilton B. Santos(Universidade Federal do Rio Grande do Norte), Renzo Guerrini(Meyer Children's Hospital), Chiara Ruzza(University of Ferrara), Girolamo Calò(University of Padua), Laila Asth(Universidade Federal do Rio Grande do Norte)
Psychopharmacology
August 25, 2018
10.1007/s00213-018-5004-7
Cited by 25

Related Papers

The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1
|Epilepsia|2010|1.7k
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
|Nature|2012|474
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432
Somatic Mutations in Cerebral Cortical Malformations
|New England Journal of Medicine|2014|394